These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1572027)

  • 1. Clinical experience with a tiered-therapy, multiprogrammable antiarrhythmia device.
    Bardy GH; Troutman C; Poole JE; Kudenchuk PJ; Dolack GL; Johnson G; Hofer B
    Circulation; 1992 May; 85(5):1689-98. PubMed ID: 1572027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.
    Fromer M; Brachmann J; Block M; Siebels J; Hoffmann E; Almendral J; Ohm OJ; den Dulk K; Coumel P; Camm AJ
    Circulation; 1992 Aug; 86(2):363-74. PubMed ID: 1638705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction in defibrillator shocks with an implantable device combining antitachycardia pacing and shock therapy.
    Leitch JW; Gillis AM; Wyse DG; Yee R; Klein GJ; Guiraudon G; Sheldon RS; Duff HJ; Kieser TM; Mitchell LB
    J Am Coll Cardiol; 1991 Jul; 18(1):145-51. PubMed ID: 2050917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term multicenter experience with a second-generation implantable pacemaker-defibrillator in patients with malignant ventricular tachyarrhythmias. The Guardian Multicenter Investigators Group.
    Saksena S; Poczobutt-Johanos M; Castle LW; Fogoros RN; Alpert BL; Kron J; Pacifico A; Griffin J; Ruskin JN; Kehoe RF
    J Am Coll Cardiol; 1992 Mar; 19(3):490-9. PubMed ID: 1537999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial clinical experience with the pacemaker-cardioverter-defibrillator.
    Yee R; Klein GJ; Guiraudon GM; Jones DL; Sharma AD; Norris C
    Can J Cardiol; 1990 May; 6(4):147-56. PubMed ID: 2344560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with a third-generation implantable cardioverter-defibrillator.
    Saksena S; Mehta D; Krol RB; Tullo NG; Saxena A; Kaushik R; Neglia J
    Am J Cardiol; 1991 Jun; 67(16):1375-84. PubMed ID: 2042568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implantable transvenous cardioverter-defibrillators.
    Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
    Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The initial clinical experience with an implantable cardioverter defibrillator/antitachycardia pacemaker.
    Singer I; Austin E; Nash W; Gilbo J; Kupersmith J
    Pacing Clin Electrophysiol; 1991 Jul; 14(7):1119-28. PubMed ID: 1715549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].
    Schmitt C; Brachmann J; Saggau W; Beyer T; Waldecker B; Scharowski K; Hilbel T; Montero M; Offner B; Schöls W
    Z Kardiol; 1991 Nov; 80(11):665-72. PubMed ID: 1792808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective randomized repeat-crossover comparison of antitachycardia pacing with low-energy cardioversion.
    Bardy GH; Poole JE; Kudenchuk PJ; Dolack GL; Kelso D; Mitchell R
    Circulation; 1993 Jun; 87(6):1889-96. PubMed ID: 8504501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of ventricular fibrillation with transvenous defibrillators without baseline electrophysiologic testing or antiarrhythmic drugs.
    Dolack GL; Poole JE; Kudenchuk PJ; Raitt MH; Gleva MJ; Anderson J; Troutman C; Bardy GH
    J Cardiovasc Electrophysiol; 1996 Mar; 7(3):197-202. PubMed ID: 8867293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of a sequential pacing and high-energy bidirectional shock algorithm for transvenous cardioversion in patients with ventricular tachycardia.
    Lindsay BD; Saksena S; Rothbart ST; Wasty N; Pantopoulos D
    Circulation; 1987 Sep; 76(3):601-9. PubMed ID: 3621521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Initial clinical experience with endocardial defibrillation using an implantable cardioverter/defibrillator with a triple-electrode system.
    Saksena S; Tullo NG; Krol RB; Mauro AM
    Arch Intern Med; 1989 Oct; 149(10):2333-9. PubMed ID: 2802898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical transvenous cardioversion of recurrent life-threatening ventricular tachyarrhythmias: low energy synchronized cardioversion of ventricular tachycardia and termination of ventricular fibrillation in patients using a catheter electrode.
    Zipes DP; Jackman WM; Heger JJ; Chilson DA; Browne KF; Naccarelli GV; Rahilly GT; Prystowsky EN
    Am Heart J; 1982 May; 103(5):789-94. PubMed ID: 7072583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential transvenous pacing and shock therapy for termination of sustained ventricular tachycardia.
    Calvo RA; Saksena S; Pantopoulos D
    Am Heart J; 1988 Mar; 115(3):569-75. PubMed ID: 3344658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved patient surveillance and data acquisition with a third generation implantable cardioverter defibrillator.
    Luceri RM; Puchferran RL; Brownstein SL; Habal SM; David IB; Vardeman LL
    Pacing Clin Electrophysiol; 1991 Nov; 14(11 Pt 2):1870-4. PubMed ID: 1721191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system.
    Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A
    Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-hospital experience with multiprogrammable implantable antitachycardia/antifibrillation devices.
    Waldecker B; Brachmann J; Schmitt C; Offner B; Hurst T; Saggau W; Hagl S; Dapper F; Hehrlein F; Tillmanns H
    Eur Heart J; 1993 Apr; 14(4):492-8. PubMed ID: 8472712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implanted automatic defibrillators: effects of drugs and pacemakers.
    Singer I; Guarnieri T; Kupersmith J
    Pacing Clin Electrophysiol; 1988 Dec; 11(12):2250-62. PubMed ID: 2463613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of electrical pacemakers in the treatment of ventricular tachycardia and ventricular fibrillation.
    Kerr CR; Klein GJ; Cooper JA; Sharma AD
    Cardiovasc Clin; 1985; 16(1):215-37. PubMed ID: 3915712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.